{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:42:10Z","timestamp":1792644130554,"version":"4.5.0"},"reference-count":162,"publisher":"European Respiratory Society (ERS)","issue":"157","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2020,3,20]]},"published-print":{"date-parts":[[2020,9,30]]},"abstract":"<jats:p>Primary Sjogren syndrome (pSS) is a systemic autoimmune disease characterised by lymphocytic infiltration of exocrine glands and by a number of systemic manifestations, including those regarding the lung. Pulmonary involvement in pSS includes interstitial lung disease (ILD) and airway disease, together with lymphoproliferative disorders.<\/jats:p>\n                  <jats:p>Patients with pSS-ILD report impaired health-related quality of life and a higher risk of death, suggesting the importance of early diagnosis and treatment of this type of pulmonary involvement. In contrast, airway disease usually has little effect on respiratory function and is rarely the cause of death in these patients.<\/jats:p>\n                  <jats:p>More rare disorders can be also identified, such as pleural effusion, cysts or bullae.<\/jats:p>\n                  <jats:p>Up to date, available data do not allow us to establish an evidence-based treatment strategy in pSS-ILD. No data are available regarding which patients should be treated, the timing to start therapy and better therapeutic options. The lack of knowledge about the natural history and prognosis of pSS-ILD is the main limitation to the development of clinical trials or shared recommendations on this topic. However, a recent trial showed the efficacy of the antifibrotic drug nintedanib in slowing progression of various ILDs, including those in pSS patients.<\/jats:p>","DOI":"10.1183\/16000617.0021-2020","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T06:35:19Z","timestamp":1597818919000},"page":"200021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":84,"title":["Lung complications of Sjogren syndrome"],"prefix":"10.1183","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5775-5947","authenticated-orcid":false,"given":"Fabrizio","family":"Luppi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Sverzellati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cavazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreina","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"2024102403474410000_29.157.200021.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66990-5"},{"key":"2024102403474410000_29.157.200021.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205375"},{"key":"2024102403474410000_29.157.200021.3","first-page":"247","article-title":"The epidemiology of Sj\u00f6gren's syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"2024102403474410000_29.157.200021.4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ccm.2019.05.002","article-title":"Pulmonary involvement in Sj\u00f6gren syndrome","volume":"40","author":"Natalini","year":"2019","journal-title":"Clin Chest Med"},{"key":"2024102403474410000_29.157.200021.5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev200"},{"key":"2024102403474410000_29.157.200021.6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes311"},{"key":"2024102403474410000_29.157.200021.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1152-8"},{"key":"2024102403474410000_29.157.200021.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.5.1489"},{"key":"2024102403474410000_29.157.200021.9","doi-asserted-by":"publisher","DOI":"10.1136\/thx.46.3.180"},{"key":"2024102403474410000_29.157.200021.10","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/18937619"},{"key":"2024102403474410000_29.157.200021.11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren's syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"New Engl J Med"},{"key":"2024102403474410000_29.157.200021.12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2024102403474410000_29.157.200021.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.04.009"},{"key":"2024102403474410000_29.157.200021.14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1573397112666160714164149","article-title":"Update on pathogenesis of Sjogren's syndrome","volume":"13","author":"Sandhya","year":"2017","journal-title":"Curr Rheumatol Rev"},{"key":"2024102403474410000_29.157.200021.15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7150\/ijms.17718","article-title":"Reviewing primary Sj\u00f6gren's syndrome: beyond the dryness - from pathophysiology to diagnosis and treatment","volume":"14","author":"Both","year":"2017","journal-title":"Int J Med Sci"},{"key":"2024102403474410000_29.157.200021.16","doi-asserted-by":"crossref","unstructured":"Bodewes ILA , Bj\u00f6rk A , Versnel MA , et al. Innate immunity and interferons in the pathogenesis of Sj\u00f6gren's syndrome. Rheumatology (Oxford) 2019; https:\/\/doi.org\/10.1093\/rheumatology\/key360.","DOI":"10.1093\/rheumatology\/key360"},{"key":"2024102403474410000_29.157.200021.17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rdc.2017.06.002","article-title":"Neurologic manifestations of primary Sj\u00f6gren syndrome","volume":"43","author":"Margaretten","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"key":"2024102403474410000_29.157.200021.18","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1080\/14767058.2017.1334048","article-title":"Fetal and neonatal involvement in maternal rheumatologic disease","volume":"31","author":"Iijima","year":"2018","journal-title":"J Matern Neonatal Med"},{"key":"2024102403474410000_29.157.200021.19","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/16-024"},{"key":"2024102403474410000_29.157.200021.20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00431-016-2748-0","article-title":"Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management","volume":"175","author":"Baruteau","year":"2016","journal-title":"Eur J Pediatr"},{"key":"2024102403474410000_29.157.200021.21","doi-asserted-by":"crossref","unstructured":"Sambataro G , Ferro F , Orlandi M , et al. Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sj\u00f6gren's syndrome: a systematic review from the Italian Society of Rheumatology. Autoimmun Rev 2020: 102447. doi:10.1016\/j.autrev.2019.102447","DOI":"10.1016\/j.autrev.2019.102447"},{"key":"2024102403474410000_29.157.200021.22","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200207000-00003"},{"key":"2024102403474410000_29.157.200021.23","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.21037\/jtd.2018.03.120","article-title":"Risk factors for primary Sj\u00f6gren syndrome-associated interstitial lung disease","volume":"10","author":"Wang","year":"2018","journal-title":"J Thorac Dis"},{"key":"2024102403474410000_29.157.200021.24","doi-asserted-by":"crossref","unstructured":"Miyamoto ST , Valim V , Fisher BA . Health-related quality of life and costs in Sj\u00f6gren's syndrome. Rheumatology (Oxford) 2019; in press [https:\/\/doi.org\/10.1093\/rheumatology\/key370].","DOI":"10.1093\/rheumatology\/key370"},{"key":"2024102403474410000_29.157.200021.25","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00829-2015"},{"key":"2024102403474410000_29.157.200021.26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-019-0875-x","article-title":"Diagnostic accuracy of a Velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device)","volume":"19","author":"Manfredi","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2024102403474410000_29.157.200021.27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12890-018-0670-0","article-title":"\u201cVelcro-type\u201d crackles predict specific radiologic features of fibrotic interstitial lung disease","volume":"18","author":"Sgalla","year":"2018","journal-title":"BMC Pulm Med"},{"key":"2024102403474410000_29.157.200021.28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.compbiomed.2018.03.006","article-title":"Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis","volume":"96","author":"Pancaldi","year":"2018","journal-title":"Comput Biol Med"},{"key":"2024102403474410000_29.157.200021.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200403-417OC"},{"key":"2024102403474410000_29.157.200021.30","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0011-2016"},{"key":"2024102403474410000_29.157.200021.31","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.1.61"},{"key":"2024102403474410000_29.157.200021.32","doi-asserted-by":"publisher","DOI":"10.1002\/art.30077"},{"key":"2024102403474410000_29.157.200021.33","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2306"},{"key":"2024102403474410000_29.157.200021.34","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.149"},{"key":"2024102403474410000_29.157.200021.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61079-4"},{"key":"2024102403474410000_29.157.200021.36","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.9.709"},{"key":"2024102403474410000_29.157.200021.37","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.40130","article-title":"Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2024102403474410000_29.157.200021.38","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00131813"},{"key":"2024102403474410000_29.157.200021.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.07.022"},{"key":"2024102403474410000_29.157.200021.40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijcard.2016.03.084","article-title":"Six-minute walk test in systemic sclerosis: a systematic review and meta-analysis","volume":"212","author":"Vandecasteele","year":"2016","journal-title":"Int J Cardiol"},{"key":"2024102403474410000_29.157.200021.41","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-488OC"},{"key":"2024102403474410000_29.157.200021.42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1753465816676048","article-title":"Current best practice in rehabilitation in interstitial lung disease","volume":"11","author":"Nakazawa","year":"2017","journal-title":"Ther Adv Respir Dis"},{"issue":"Suppl. 1","key":"2024102403474410000_29.157.200021.43","first-page":"161","article-title":"Usefulness of six-minute walk test in systemic sclerosis","volume":"36","author":"Rizzi","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2024102403474410000_29.157.200021.44","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1371529"},{"key":"2024102403474410000_29.157.200021.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)32278-7"},{"key":"2024102403474410000_29.157.200021.46","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10067-017-3601-1","article-title":"Prevalence and characterization of non-sicca onset primary Sj\u00f6gren syndrome with interstitial lung involvement","volume":"36","author":"Manfredi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2024102403474410000_29.157.200021.47","doi-asserted-by":"crossref","first-page":"e0180283","DOI":"10.1371\/journal.pone.0180283","article-title":"Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease","volume":"12","author":"Enomoto","year":"2017","journal-title":"PLoS One"},{"key":"2024102403474410000_29.157.200021.48","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s10067-018-4128-9","article-title":"Acute fibrinous and organizing pneumonia as initial presentation of primary Sj\u00f6gren's syndrome: a case report and literature review","volume":"37","author":"Wang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2024102403474410000_29.157.200021.49","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e328363f48d"},{"key":"2024102403474410000_29.157.200021.50","doi-asserted-by":"publisher","DOI":"10.1378\/chest.94.2.438"},{"key":"2024102403474410000_29.157.200021.51","first-page":"2235","article-title":"Cystic lung disease in Sj\u00f6gren's syndrome","volume":"29","author":"Hubscher","year":"2002","journal-title":"J Rheumatol"},{"key":"2024102403474410000_29.157.200021.52","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318181e6af"},{"key":"2024102403474410000_29.157.200021.53","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-5231(05)70110-6"},{"key":"2024102403474410000_29.157.200021.54","first-page":"e11003","article-title":"Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sj\u00f6gren syndrome patients: a case-control study","volume":"97","author":"Gao","year":"2018","journal-title":"Med (United States)"},{"key":"2024102403474410000_29.157.200021.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.12.019"},{"key":"2024102403474410000_29.157.200021.56","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0801CI"},{"key":"2024102403474410000_29.157.200021.57","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.21037\/jtd.2019.03.28","article-title":"Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature","volume":"11","author":"Manfredi","year":"2019","journal-title":"J Thorac Dis"},{"key":"2024102403474410000_29.157.200021.58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11739-015-1204-x","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review","volume":"10","author":"Luppi","year":"2015","journal-title":"Intern Emerg Med"},{"key":"2024102403474410000_29.157.200021.59","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1148\/rg.337125107","article-title":"CT findings of thoracic manifestations of primary Sj\u00f6gren syndrome: radiologic-pathologic correlation","volume":"33","author":"Egashira","year":"2013","journal-title":"Radiographics"},{"key":"2024102403474410000_29.157.200021.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2004.01.006"},{"key":"2024102403474410000_29.157.200021.61","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.169.3.9275871"},{"key":"2024102403474410000_29.157.200021.62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3904\/kjim.2007.22.3.192","article-title":"Pulmonary nodular lymphoid hyperplasia associated with Sj\u00f6gren's syndrome","volume":"22","author":"Song","year":"2007","journal-title":"Korean J Intern Med"},{"key":"2024102403474410000_29.157.200021.63","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.chest.2016.05.015","article-title":"Cystic lung disease among patients with Sj\u00f6gren syndrome: frequency, natural history, and associated risk factors","volume":"150","author":"Mart\u00ednez-Balzano","year":"2016","journal-title":"Chest"},{"key":"2024102403474410000_29.157.200021.64","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-200411000-00008"},{"key":"2024102403474410000_29.157.200021.65","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(03)00102-2"},{"key":"2024102403474410000_29.157.200021.66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rmed.2018.02.023","article-title":"Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sj\u00f6gren's syndrome","volume":"137","author":"Kakugawa","year":"2018","journal-title":"Respir Med"},{"key":"2024102403474410000_29.157.200021.67","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-001-1236-7"},{"key":"2024102403474410000_29.157.200021.68","doi-asserted-by":"publisher","DOI":"10.1097\/00005382-200110000-00009"},{"key":"2024102403474410000_29.157.200021.69","doi-asserted-by":"publisher","DOI":"10.1097\/00005382-200110000-00010"},{"key":"2024102403474410000_29.157.200021.70","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-199903000-00002"},{"key":"2024102403474410000_29.157.200021.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.08.009"},{"key":"2024102403474410000_29.157.200021.72","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/16420165"},{"key":"2024102403474410000_29.157.200021.73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40248-019-0179-2","article-title":"Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases","volume":"14","author":"Ciancio","year":"2019","journal-title":"Multidiscip Respir Med"},{"key":"2024102403474410000_29.157.200021.74","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780301104"},{"key":"2024102403474410000_29.157.200021.75","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-005-0092-1"},{"key":"2024102403474410000_29.157.200021.76","doi-asserted-by":"publisher","DOI":"10.1378\/chest.88.2.226"},{"key":"2024102403474410000_29.157.200021.77","first-page":"831","article-title":"Pleuropulmonary abnormalities in primary Sjogren's syndrome","volume":"20","author":"Gardiner","year":"1993","journal-title":"J Rheumatol"},{"key":"2024102403474410000_29.157.200021.78","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.2.9610076"},{"key":"2024102403474410000_29.157.200021.79","first-page":"349","article-title":"A longitudinal study of lung impairment in patients with primary Sjogren's syndrome","volume":"15","author":"Mialon","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"2024102403474410000_29.157.200021.80","doi-asserted-by":"publisher","DOI":"10.3109\/03009749509095167"},{"key":"2024102403474410000_29.157.200021.81","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1183\/09031936.93.03050548","article-title":"Increased bronchial responsiveness in primary and secondary Sjogren's syndrome","volume":"3","author":"Potena","year":"1990","journal-title":"Eur Respir J"},{"key":"2024102403474410000_29.157.200021.82","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.1.36"},{"key":"2024102403474410000_29.157.200021.83","first-page":"125","article-title":"Increased bronchial responsiveness in primary Sjogren's syndrome. A sign of tracheobronchial involvement","volume":"9","author":"La Corte","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"2024102403474410000_29.157.200021.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.07.017"},{"key":"2024102403474410000_29.157.200021.85","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0272-5231(21)00929-1","article-title":"Bronchiolitis in association with connective tissue disorders","volume":"14","author":"Wells","year":"1993","journal-title":"Clin Chest Med"},{"key":"2024102403474410000_29.157.200021.86","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000121237.98962.1e"},{"key":"2024102403474410000_29.157.200021.87","doi-asserted-by":"publisher","DOI":"10.1002\/art.22536"},{"key":"2024102403474410000_29.157.200021.88","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.057919"},{"key":"2024102403474410000_29.157.200021.89","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201411-2094CI"},{"key":"2024102403474410000_29.157.200021.90","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1513\/AnnalsATS.201511-759BC","article-title":"Diffuse cystic lung disease as the presenting manifestation of Sj\u00f6gren syndrome","volume":"13","author":"Gupta","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2024102403474410000_29.157.200021.91","first-page":"193","article-title":"Pleurisy in primary Sjogren's syndrome: T-cell receptor \u03b2-chain variable region gene bias and local autoantibody production in the pleural effusion","volume":"15","author":"Kawamata","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"2024102403474410000_29.157.200021.92","first-page":"15322","article-title":"Primary Sj\u00f6gren's syndrome accompanied by pleural effusion: a case report and literature review","volume":"8","author":"Ma","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"2024102403474410000_29.157.200021.93","first-page":"65","article-title":"Shrinking lung syndrome and pleural effusion as an initial manifestation of primary Sj\u00f6gren's syndrome","volume":"16","author":"Baenas","year":"2019","journal-title":"Reumatol Cl\u00ednica (English Ed)"},{"key":"2024102403474410000_29.157.200021.94","doi-asserted-by":"crossref","first-page":"e00285","DOI":"10.1002\/rcr2.285","article-title":"Pleuritis associated with primary Sjogren syndrome","volume":"6","author":"Hosoda","year":"2018","journal-title":"Respirol Case Rep"},{"key":"2024102403474410000_29.157.200021.95","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1440-1843.2007.01149.x","article-title":"Primary Sjogren's syndrome complicated by bilateral pleural effusion","volume":"13","author":"Teshigawara","year":"2008","journal-title":"Respirology"},{"key":"2024102403474410000_29.157.200021.96","first-page":"13","article-title":"Pleural effusion in a patient with primary Sj\u00f6gren's syndrome successfully treated with corticosteroids","volume":"107","author":"Cruz-P\u00e9rez Fdel","year":"2015","journal-title":"Bol Asoc Med P R"},{"key":"2024102403474410000_29.157.200021.97","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2169\/internalmedicine.46.0062","article-title":"Successful treatment of a patient with primary Sj\u00f6gren's syndrome complicated with pericarditis during pregnancy","volume":"46","author":"Mutsukura","year":"2007","journal-title":"Intern Med"},{"key":"2024102403474410000_29.157.200021.98","first-page":"647","article-title":"Bronchiectasis in primary Sj\u00f6gren's syndrome: prevalence and clinical significance","volume":"28","author":"Soto-Cardenas","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2024102403474410000_29.157.200021.99","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1177\/0961203317716306","article-title":"Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: a Danish nationwide cohort study","volume":"26","author":"Ahlehoff","year":"2017","journal-title":"Lupus"},{"key":"2024102403474410000_29.157.200021.100","doi-asserted-by":"publisher","DOI":"10.1191\/0961203304lu1006oa"},{"key":"2024102403474410000_29.157.200021.101","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/acr.22968","article-title":"Treatment guidelines for rheumatologic manifestations of Sj\u00f6gren's syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain","volume":"69","author":"Carsons","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2024102403474410000_29.157.200021.102","first-page":"1900","article-title":"Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatol (United Kingdom)"},{"key":"2024102403474410000_29.157.200021.103","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028466"},{"key":"2024102403474410000_29.157.200021.104","first-page":"2031","article-title":"The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatment","volume":"58","author":"Duarte","year":"2019","journal-title":"Rheumatol (United Kingdom)"},{"key":"2024102403474410000_29.157.200021.105","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.20.2337"},{"key":"2024102403474410000_29.157.200021.106","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.041186"},{"key":"2024102403474410000_29.157.200021.107","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.04.006"},{"key":"2024102403474410000_29.157.200021.108","doi-asserted-by":"publisher","DOI":"10.1002\/art.10221"},{"key":"2024102403474410000_29.157.200021.109","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203305"},{"key":"2024102403474410000_29.157.200021.110","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000209423.39033.94"},{"key":"2024102403474410000_29.157.200021.111","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12308-017-0302-2","article-title":"Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma","volume":"10","author":"Schreuder","year":"2017","journal-title":"J Hematop"},{"key":"2024102403474410000_29.157.200021.112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2010.05.007"},{"key":"2024102403474410000_29.157.200021.113","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.04.005"},{"key":"2024102403474410000_29.157.200021.114","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2017.1341"},{"key":"2024102403474410000_29.157.200021.115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2018.08.007","article-title":"Lymphomagenesis in Sj\u00f6gren's syndrome: predictive biomarkers towards precision medicine","volume":"18","author":"Goules","year":"2019","journal-title":"Autoimmun Rev"},{"key":"2024102403474410000_29.157.200021.116","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12026-016-8844-4","article-title":"Primary Sj\u00f6gren's syndrome: clinical phenotypes, outcome and the development of biomarkers","volume":"65","author":"Goules","year":"2017","journal-title":"Immunol Res"},{"key":"2024102403474410000_29.157.200021.117","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181b76ab5"},{"key":"2024102403474410000_29.157.200021.118","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61219-1"},{"key":"2024102403474410000_29.157.200021.119","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.04.014"},{"key":"2024102403474410000_29.157.200021.120","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000067972"},{"key":"2024102403474410000_29.157.200021.121","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1148\/rg.2016140339","article-title":"Primary pulmonary lymphoid lesions: radiologic and pathologic findings","volume":"36","author":"Sirajuddin","year":"2016","journal-title":"RadioGraphics"},{"key":"2024102403474410000_29.157.200021.122","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-041863"},{"key":"2024102403474410000_29.157.200021.123","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00039309"},{"key":"2024102403474410000_29.157.200021.124","first-page":"284","article-title":"Case review of sarcoidosis resembling Sjogren's syndrome","volume":"2","author":"Ahmad","year":"2010","journal-title":"J Clin Med Res"},{"key":"2024102403474410000_29.157.200021.125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5114\/reum.2019.83242","article-title":"Sj\u00f6gren's syndrome and lymphadenopathy unraveling the diagnosis of Lyme disease","volume":"57","author":"Smiyan","year":"2019","journal-title":"Reumatologia"},{"key":"2024102403474410000_29.157.200021.126","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0056-2017"},{"key":"2024102403474410000_29.157.200021.127","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181579781"},{"key":"2024102403474410000_29.157.200021.128","first-page":"109","article-title":"Is the heart affected in primary Sj\u00f6gren's syndrome? An echocardiographic study","volume":"26","author":"Vassiliou","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2024102403474410000_29.157.200021.129","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","article-title":"Interstitial lung disease in primary Sj\u00f6gren's syndrome","volume":"16","author":"Roca","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2024102403474410000_29.157.200021.130","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.53"},{"key":"2024102403474410000_29.157.200021.131","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.3.8810621"},{"key":"2024102403474410000_29.157.200021.132","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","article-title":"Treatment of primary Sj\u00f6gren syndrome","volume":"12","author":"Saraux","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2024102403474410000_29.157.200021.133","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121043"},{"key":"2024102403474410000_29.157.200021.134","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.autrev.2018.12.008","article-title":"The 2018 pipeline of targeted therapies under clinical development for systemic lupus erythematosus: a systematic review of trials","volume":"18","author":"Felten","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2024102403474410000_29.157.200021.135","doi-asserted-by":"crossref","unstructured":"Mavragani CP , Moutsopoulos HM . Sj\u00f6gren's syndrome: old and new therapeutic targets. J Autoimmun 2019: 102364. doi:10.1016\/j.jaut.2019.102364","DOI":"10.1016\/j.jaut.2019.102364"},{"key":"2024102403474410000_29.157.200021.136","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.11.014"},{"key":"2024102403474410000_29.157.200021.137","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40262-015-0240-z","article-title":"Pharmacokinetics and pharmacokinetic\/pharmacodynamic modeling of filgotinib (GLPG0634), a selective JAK1 inhibitor, in support of phase IIb dose selection","volume":"54","author":"Namour","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"2024102403474410000_29.157.200021.138","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41598-018-20390-5","article-title":"Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages\/microglia through an NF-\u03baB pathway","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep"},{"key":"2024102403474410000_29.157.200021.139","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12649"},{"key":"2024102403474410000_29.157.200021.140","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/0961203316678675","article-title":"Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study","volume":"26","author":"Burge","year":"2017","journal-title":"Lupus"},{"key":"2024102403474410000_29.157.200021.141","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214720"},{"key":"2024102403474410000_29.157.200021.142","first-page":"1784","article-title":"The novel anti-CD40 monoclonal antibody CFZ533 shows beneficial effects in patients with primary Sj\u00f6gren's syndrome: a phase IIa double-blind, placebo-controlled randomized trial","volume":"69","author":"Fischer","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2024102403474410000_29.157.200021.143","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12890-017-0462-y","article-title":"Exploring efficacy and safety of oral pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial","volume":"17","author":"Behr","year":"2017","journal-title":"BMC Pulm Med"},{"key":"2024102403474410000_29.157.200021.144","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s12325-019-01086-2","article-title":"The design and rationale of the Trail1 trial: a randomized double-blind phase 2 clinical trial of pirfenidone in rheumatoid arthritis-associated interstitial lung disease","volume":"36","author":"Solomon","year":"2019","journal-title":"Adv Ther"},{"key":"2024102403474410000_29.157.200021.145","unstructured":"ClinicalTrials.gov . An Expanded Access Program to Provide Nintedanib to Patients with Non-IPF ILD Who Have no Alternative Treatment PossibilitiesDate last updated: 8 April 2020; date last accessed: 8 April 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT03843892."},{"key":"2024102403474410000_29.157.200021.146","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13063-017-2016-2","article-title":"Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial","volume":"18","author":"Saunders","year":"2017","journal-title":"Trials"},{"key":"2024102403474410000_29.157.200021.147","unstructured":"ClinicalTrials.gov . Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate (SLSIII). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03221257 Date last updated: 21 February 2020; date last accessed: 7 December 2019."},{"key":"2024102403474410000_29.157.200021.148","unstructured":"ClinicalTrials.gov . Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease (ATtackMy-ILD). www.clinicaltrials.gov\/ct2\/show\/NCT03215927 Date last updated: 14 July 2020; date last accessed: 15 January 2020."},{"key":"2024102403474410000_29.157.200021.149","doi-asserted-by":"publisher","DOI":"10.1159\/000214841"},{"key":"2024102403474410000_29.157.200021.150","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202293"},{"key":"2024102403474410000_29.157.200021.151","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"2024102403474410000_29.157.200021.152","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MCP.0b013e3283567ff9","article-title":"The big clinical trials in idiopathic pulmonary fibrosis","volume":"18","author":"Luppi","year":"2012","journal-title":"Curr Opin Pulm Med"},{"key":"2024102403474410000_29.157.200021.153","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"2024102403474410000_29.157.200021.154","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"2024102403474410000_29.157.200021.155","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151322"},{"key":"2024102403474410000_29.157.200021.156","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"},{"key":"2024102403474410000_29.157.200021.157","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2017-000212"},{"key":"2024102403474410000_29.157.200021.158","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2024102403474410000_29.157.200021.159","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0076-2017"},{"key":"2024102403474410000_29.157.200021.160","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-206865"},{"key":"2024102403474410000_29.157.200021.161","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","article-title":"Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial","volume":"6","author":"Visca","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102403474410000_29.157.200021.162","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6819"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0021-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:01:46Z","timestamp":1740355306000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0021-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":162,"journal-issue":{"issue":"157","published-online":{"date-parts":[[2020,8,18]]},"published-print":{"date-parts":[[2020,9,30]]}},"alternative-id":["10.1183\/16000617.0021-2020"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0021-2020","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]}}}